405 related articles for article (PubMed ID: 9823775)
1. High mobility group I/Y protein functions as a specific cofactor for Oct-2A: mapping of interaction domains.
Abdulkadir SA; Casolaro V; Tai AK; Thanos D; Ono SJ
J Leukoc Biol; 1998 Nov; 64(5):681-91. PubMed ID: 9823775
[TBL] [Abstract][Full Text] [Related]
2. Functional roles of the transcription factor Oct-2A and the high mobility group protein I/Y in HLA-DRA gene expression.
Abdulkadir SA; Krishna S; Thanos D; Maniatis T; Strominger JL; Ono SJ
J Exp Med; 1995 Aug; 182(2):487-500. PubMed ID: 7629508
[TBL] [Abstract][Full Text] [Related]
3. Oct-1 maintains an intermediate, stable state of HLA-DRA promoter repression in Rb-defective cells: an Oct-1-containing repressosome that prevents NF-Y binding to the HLA-DRA promoter.
Osborne AR; Zhang H; Fejer G; Palubin KM; Niesen MI; Blanck G
J Biol Chem; 2004 Jul; 279(28):28911-9. PubMed ID: 15105429
[TBL] [Abstract][Full Text] [Related]
4. Functional interaction between the POU domain protein Tst-1/Oct-6 and the high-mobility-group protein HMG-I/Y.
Leger H; Sock E; Renner K; Grummt F; Wegner M
Mol Cell Biol; 1995 Jul; 15(7):3738-47. PubMed ID: 7791781
[TBL] [Abstract][Full Text] [Related]
5. The B cell coactivator Bob1 shows DNA sequence-dependent complex formation with Oct-1/Oct-2 factors, leading to differential promoter activation.
Gstaiger M; Georgiev O; van Leeuwen H; van der Vliet P; Schaffner W
EMBO J; 1996 Jun; 15(11):2781-90. PubMed ID: 8654375
[TBL] [Abstract][Full Text] [Related]
6. POU domain factors in neural development.
Schonemann MD; Ryan AK; Erkman L; McEvilly RJ; Bermingham J; Rosenfeld MG
Adv Exp Med Biol; 1998; 449():39-53. PubMed ID: 10026784
[TBL] [Abstract][Full Text] [Related]
7. In vivo footprint analysis of the HLA-DRA gene promoter: cell-specific interaction at the octamer site and up-regulation of X box binding by interferon gamma.
Wright KL; Ting JP
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7601-5. PubMed ID: 1502171
[TBL] [Abstract][Full Text] [Related]
8. High mobility group protein 2 functionally interacts with the POU domains of octamer transcription factors.
Zwilling S; König H; Wirth T
EMBO J; 1995 Mar; 14(6):1198-208. PubMed ID: 7720710
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of cis-linked regulatory sequences in the HLA DRA promoter by transcription in vitro.
Hume CR; Lee JS
Tissue Antigens; 1990 Sep; 36(3):108-15. PubMed ID: 2278044
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase activity represses gamma interferon-inducible HLA-DR gene expression following the establishment of a DNase I-hypersensitive chromatin conformation.
Osborne A; Zhang H; Yang WM; Seto E; Blanck G
Mol Cell Biol; 2001 Oct; 21(19):6495-506. PubMed ID: 11533238
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor interactions with Oct-1 and Brn-1 are physically and functionally distinct.
González MI; Tovaglieri A; Robins DM
Mol Cell Endocrinol; 2002 Apr; 190(1-2):39-49. PubMed ID: 11997177
[TBL] [Abstract][Full Text] [Related]
12. The Oct-1 POU domain mediates interactions between Oct-1 and other POU proteins.
Verrijzer CP; van Oosterhout JA; van der Vliet PC
Mol Cell Biol; 1992 Feb; 12(2):542-51. PubMed ID: 1346336
[TBL] [Abstract][Full Text] [Related]
13. Repression of Ets-2-induced transactivation of the tau interferon promoter by Oct-4.
Ezashi T; Ghosh D; Roberts RM
Mol Cell Biol; 2001 Dec; 21(23):7883-91. PubMed ID: 11689681
[TBL] [Abstract][Full Text] [Related]
14. Differential in vivo activation of the class II and class III snRNA genes by the POU-specific domain of Oct-1.
Murphy S
Nucleic Acids Res; 1997 Jun; 25(11):2068-76. PubMed ID: 9153304
[TBL] [Abstract][Full Text] [Related]
15. Segments of the POU domain influence one another's DNA-binding specificity.
Aurora R; Herr W
Mol Cell Biol; 1992 Feb; 12(2):455-67. PubMed ID: 1732727
[TBL] [Abstract][Full Text] [Related]
16. The function of the octamer-binding site in the DRA promoter.
Voliva CF; Jabrane-Ferrat N; Peterlin BM
Immunogenetics; 1996; 43(1-2):20-6. PubMed ID: 8537118
[TBL] [Abstract][Full Text] [Related]
17. Formation of a regulatory factor X/X2 box-binding protein/nuclear factor-Y multiprotein complex on the conserved regulatory regions of HLA class II genes.
Louis-Plence P; Moreno CS; Boss JM
J Immunol; 1997 Oct; 159(8):3899-909. PubMed ID: 9378978
[TBL] [Abstract][Full Text] [Related]
18. Astrocytes and glioblastoma cells express novel octamer-DNA binding proteins distinct from the ubiquitous Oct-1 and B cell type Oct-2 proteins.
Schreiber E; Harshman K; Kemler I; Malipiero U; Schaffner W; Fontana A
Nucleic Acids Res; 1990 Sep; 18(18):5495-503. PubMed ID: 2216722
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional activation by Oct-3: evidence for a specific role of the POU-specific domain in mediating functional interaction with Oct-1.
Vigano MA; Staudt LM
Nucleic Acids Res; 1996 Jun; 24(11):2112-8. PubMed ID: 8668543
[TBL] [Abstract][Full Text] [Related]
20. Transcription factor Oct-2A contains functionally redundant activating domains and works selectively from a promoter but not from a remote enhancer position in non-lymphoid (HeLa) cells.
Müller-Immerglück MM; Schaffner W; Matthias P
EMBO J; 1990 May; 9(5):1625-34. PubMed ID: 2328728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
